Sales of Autogenous Vaccines Market to Grow at Robust CAGR 4.4% During 2019 to 2029

23/mar/2020 08:23:30 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.
 

Inadequacy of vaccines to combat increasing rare infectious diseases in livestock and companion animals is the key driving factor aiding the growth of the autogenous vaccines market. Autogenous vaccines are an efficient alternative to antibiotics that control and prevent infectious diseases.

Improvements in animal health, decreased animal suffering, efficient food production, and reduction in the need for antibiotics are boosting the adoption of autogenous vaccines in the livestock industry. Increasing animal care spending and research & development activities in the veterinary biologics sector further favors the growth of the autogenous vaccines market.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/29491

The global autogenous vaccines market was valued at US$ 428 Mn in 2018, and is expected to witness a CAGR of 4.4% over the forecast period (2019–2029).

Key Takeaways of Autogenous Vaccines Market Study

  • Bacterial strain type contributes more than 3/4 share in the autogenous vaccines market, owing to increasing rare bacterial infections among livestock and companion animals.
  • Veterinary hospitals account for half of the value share in the global autogenous vaccines market, attributed to increase in the number of veterinary hospitals and rising government funding for animal healthcare.
  • Increasing research activities in the veterinary medicine & biologics industry in the United States and rising animal healthcare expenditure have contributed to the dominance of North America in the global autogenous vaccines market.
  • Attributed to growing awareness regarding zoonotic diseases and increasing funding for animal disease eradication, China, Brazil, and India are expected to offer notable growth opportunities for the autogenous vaccines market.

“Unavailability of licensed vaccines for bacterial and viral infections in animals has directed the focus of several small & large manufactures to invest in the manufacturing of autogenous vaccines, thereby propelling the growth of the autogenous vaccines market,” says a PMR analyst.

For Critical Insights on the Market, Request For Methodology Here @ https://www.persistencemarketresearch.com/methodology/29491

Product Portfolio Expansion through Partnerships – Key Strategy of Leading Autogenous Vaccine Manufacturers

Autogenous vaccine manufacturers are focusing on product portfolio expansion through partnerships with and acquisition of small veterinary biologics manufactures. For example, in 2018, Huvepharma acquired AgriLabs, to expand its presence in the U.S. and speed up the commercialization of biologic products for animal health. The acquisition included AgriLabs’s custom vaccines business. Moreover, in 2017, Pharmgate and Cambridge Technologies entered into a strategic alliance to provide commercial, autogenous, and prescription vaccine solutions to veterinarians.

More Valuable Insights on Autogenous Vaccines Market

Persistence Market Research offers a unique perspective and actionable insights on autogenous vaccines in its latest study, presenting historical demand assessment from 2014–2018 and projections for 2019–2029, on the basis of strain type (bacterial strain and virus strain), and end user (veterinary clinics, veterinary hospitals, and veterinary research institutes), across seven major regions.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/29491

COMPANIES COVERED IN AUTOGENOUS VACCINES MARKET REPORT

  • Newport Laboratories, Inc.
  • Elanco Animal Health
  • Ceva (Ceva Biovac)
  • Cambridge Technologies
  • Hygieia Biological Laboratories
  • Dyntec s. r. o
  • Phibro Animal Health Corporation
  • Huvepharma, Inc.
  • Deltamune
  • AniCon Labor GmbH

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Animal Healthcare Market –

According to a report published by Persistence Market Research (PMR), the global animal healthcare market is expected to witness a CAGR of 4.8% from 2017 to 2025. In 2017, the market was worth US$ 30,744.2 Mn and is estimated to rise to a valuation of US$ 44,847.2 Mn by the end of 2025.

Dental Implants Market –

According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants – Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

Bioinformatics Market –

According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.

Globally, rising R&D expenditures and a rising number of research activities have increased the demand for bioinformatics in the market. As a result, the market is expected to grow at a CAGR of about 20.4% from 2014 – 2020.

Hospital Beds Market – 

According to a new market report published by Persistence Market Research “Global Market Study on Hospital Beds: Asia to Witness Highest Growth by 2020”, the global hospital beds market was valued at USD 5,254.2 million in 2014 and is expected to expand at a CAGR of 4.2% from 2014 to 2020, to reach an estimated value of USD 6,731.8 million by 2020.

Cleanroom Technology Market –

According to a new market report published by Persistence Market Research titled Global Market Study on  Cleanroom Technology : Consumables to Witness Highest Growth by 2020, the global  cleanroom technology market  was valued at USD 3,156.0 million in 2014 and is expected to grow at a CAGR of 5.2 % from 2014 to 2020 to reach an estimated value of USD 4,290.1 ​​million by 2020.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR's collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. + 1-646-568-7751
E-mail id-  sales@persistencemarketresearch.com
Website:  https://www.persistencemarketresearch.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl